Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNS efficacy of two antiretroviral combination regimens with different CNS penetration in treatment-naive HIV-positive patients
2010-023264-40Phase 4Terminated
- Sponsor
- Fondazione IRCCS San Gerardo dei Tintori
- Start
- Dec 2010
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in human immunodeficiency virus infection (HIV) comparing Lopinavir/ritonavir + abacavir/lamivudine with Atazanavir/ritonavir + emtricitabine/tenofovir disoproxil (2 arms). Started Dec 2010; status: terminated.
02
Drugs
lopinavirritonavirabacavirlamivudineatazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-023264-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023264-40.